Simona Lapusan
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.
Journal: The Lancet. Haematology
Published: August 18, 2025
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study.
Journal: Leukemia & lymphoma
Published: April 23, 2022
Invasive Fungal Rhinosinusitis Due to Co-infection with Mucormycosis and Exserohilum rostratum in a Patient with Acute Lymphoblastic Leukemia.
Journal: Clinical hematology international
Published: November 03, 2021
Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy.
Journal: Leukemia & lymphoma
Published: January 08, 2021
Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?
Journal: Current research in translational medicine
Published: October 30, 2020
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience.
Journal: Leukemia & lymphoma
Published: October 05, 2020
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
Journal: Nature communications
Published: September 25, 2020
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 03, 2020
Last Updated: 09/26/2026